Northeast Pharmaceutical Group Co Ltd
SZSE:000597
Northeast Pharmaceutical Group Co Ltd
Cash from Operating Activities
Northeast Pharmaceutical Group Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Northeast Pharmaceutical Group Co Ltd
SZSE:000597
|
Cash from Operating Activities
¥586.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Cash from Operating Activities
¥4.7B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
4%
|
CAGR 10-Years
22%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Operating Activities
¥2.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Operating Activities
¥3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
108%
|
CAGR 10-Years
30%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Operating Activities
¥3.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Operating Activities
¥3.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
18%
|
CAGR 10-Years
26%
|
See Also
What is Northeast Pharmaceutical Group Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
586.8m
CNY
Based on the financial report for Dec 31, 2023, Northeast Pharmaceutical Group Co Ltd's Cash from Operating Activities amounts to 586.8m CNY.
What is Northeast Pharmaceutical Group Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
16%
Over the last year, the Cash from Operating Activities growth was -47%. The average annual Cash from Operating Activities growth rates for Northeast Pharmaceutical Group Co Ltd have been 1% over the past three years , 16% over the past five years .